IL-6 Receptor Blockade but Not IL-2 Treatment Contributes to Long Term NHP Cardiac Allograft Survival in Transient Mixed Chimeras.

MLA

Ahrens, K., et al. “IL-6 Receptor Blockade but Not IL-2 Treatment Contributes to Long Term NHP Cardiac Allograft Survival in Transient Mixed Chimeras.” Journal of Heart & Lung Transplantation, vol. 39, no. 4, Apr. 2020, pp. S70–71. EBSCOhost, https://doi.org/10.1016/j.healun.2020.01.1280.

APA

Ahrens, K., O, J., Sommer, W., Morrissette, J., Becerra, D., Patel, P., Costa, T., Hanekamp, I. M., Benichou, G., & Madsen, J. C. (2020). IL-6 Receptor Blockade but Not IL-2 Treatment Contributes to Long Term NHP Cardiac Allograft Survival in Transient Mixed Chimeras. Journal of Heart & Lung Transplantation, 39(4), S70–S71. https://doi.org/10.1016/j.healun.2020.01.1280

Chicago

Ahrens, K., J. O, W. Sommer, J. Morrissette, D. Becerra, P. Patel, T. Costa, I.M. Hanekamp, G. Benichou, and J.C. Madsen. 2020. “IL-6 Receptor Blockade but Not IL-2 Treatment Contributes to Long Term NHP Cardiac Allograft Survival in Transient Mixed Chimeras.” Journal of Heart & Lung Transplantation 39 (4): S70–71. doi:10.1016/j.healun.2020.01.1280.